Genesee Valley Trust’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$365K Sell
3,124
-427
-12% -$49.7K 0.15% 126
2017
Q4
$417K Sell
3,551
-110
-3% -$11.4K 0.17% 107
2017
Q3
$362K Buy
3,661
+60
+2% +$5.34K 0.15% 126
2017
Q2
$320K Sell
3,601
-5
-0.1% -$440 0.14% 143
2017
Q1
$323K Buy
3,606
+176
+5% +$15.2K 0.22% 142
2016
Q4
$296K Buy
3,430
+633
+23% +$56.5K 0.21% 146
2016
Q3
$243K Buy
2,797
+704
+34% +$70.7K 0.15% 216
2016
Q2
$223K Buy
+2,093
New +$216K 0.14% 208

Other funds holding CRI

Genesee Valley Trust's CRI Position: Q1 2018 in Review

Genesee Valley Trust reduced its Carter's (CRI) stake by 12% in Q1 2018, selling an estimated $49.7K and leaving 3,124 shares worth $365K. The position accounts for 0.15% of the portfolio, ranked #126.

Genesee Valley Trust first reported a position in CRI in Q2 2016 and has held it in 8 quarters since. The position peaked at $417K in Q4 2017. 384 funds tracked by Wall St. Rank hold CRI as of Q1 2018.

  • Genesee Valley Trust held 3,124 shares of Carter's worth $365K as of Q1 2018.
  • Genesee Valley Trust sold 427 Carter's shares in Q1 2018, an estimated $49.7K.
  • Carter's made up 0.15% of Genesee Valley Trust's portfolio in Q1 2018, its #126 holding.
  • Genesee Valley Trust first reported a position in Carter's in Q2 2016 and has held it in 8 quarters since.
  • Genesee Valley Trust's Carter's position peaked at $417K in Q4 2017.
  • 384 funds tracked by Wall St. Rank held Carter's as of Q1 2018.

Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.